Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.
Article PubMed PubMed Central Google Scholar
Barber N, Parsons J, Clifford S, et al. Patients’ problems with new medication for chronic conditions. Qual Saf Health Care. 2004;13(3):172–5.
Article PubMed PubMed Central Google Scholar
Fernandez-Lazaro CI, Adams DP, Fernandez-Lazaro D, et al. Medication adherence and barriers among low-income, uninsured patients with multiple chronic conditions. Res Social Adm Pharm. 2019;15(6):744–53.
Lauffenburger JC, Tesfaye H, Solomon DH, et al. Investigating the ability to adhere to cardiometabolic medications with different properties: a retrospective cohort study of > 500 000 patients in the USA. BMJ Open. 2023;13(11): e075840.
Article PubMed PubMed Central Google Scholar
Advanced Service Specification—NHS New Medicine Service (NMS). https://www.england.nhs.uk/wp-content/uploads/2021/10/B0936-service-specification-nhs-nms-advanced-service.pdf. Accessed 26 Mar 2025.
New Medicine Service—Intervention interview schedule. https://cpe.org.uk/wp-content/uploads/2021/08/NMS-interview-schedule-Aug-2021.pdf. Accessed 26 Mar 2025.
Elliott RA, Boyd MJ, Salema NE, et al. Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service. BMJ Qual Saf. 2016;25(10):747–58.
Ensing HT, Kurt N, Janssen RA, et al. Pharmacist-led New Medicine Service: a real-world cohort study in the Netherlands on drug-related problems, satisfaction, and self-efficacy in cardiovascular patients transitioning to primary care. Int J Clin Pharm. 2025;47(2):325–34.
Hovland R, Bremer S, Frigaard C, et al. Effect of a pharmacist-led intervention on adherence among patients with a first-time prescription for a cardiovascular medicine: a randomized controlled trial in Norwegian pharmacies. Int J Pharm Pract. 2020;28(4):337–45.
Fraeyman J, Foulon V, Mehuys E, et al. Evaluating the implementation fidelity of New Medicines Service for asthma patients in community pharmacies in Belgium. Res Social Adm Pharm. 2017;13(1):98–108.
Goncuoglu C, Kara E, Ceylan C, et al. Turkish translation and cultural adaptation of the Ascertaining Barriers to Compliance taxonomy for medication adherence. Br J Clin Pharmacol. 2025. https://doi.org/10.1002/bcp.70077.
Yagmur M, Ay P, Sancar M, et al. Validation of the Turkish version of the DOSE-nonadherence measure among patients with cardiometabolic conditions. J Clin Pharm Ther. 2022;47(10):1636–43.
Okuyan B, Ozcan V, Balta E, et al. The impact of community pharmacists on older adults in Turkey. J Am Pharm Assoc. 2021;61(6):e83–92.
Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;2014(11):CD000011.
PubMed PubMed Central Google Scholar
Easthall C, Barnett N. Using theory to explore the determinants of medication adherence; moving away from a one-size-fits-all approach. Pharmacy (Basel). 2017;5(3):50.
Allemann SS, Nieuwlaat R, van den Bemt BJ, et al. Matching adherence interventions to patient determinants using the theoretical domains framework. Front Pharmacol. 2016;7:429.
Article PubMed PubMed Central Google Scholar
Doucette WR, Farris KB, Youland KM, et al. Development of the drug adherence work-up (DRAW) tool. J Am Pharm Assoc. 2012;52(6):e199-204.
Lee S, Bae YH, Worley M, et al. Validating the modified drug adherence work-up (M-DRAW) tool to identify and address barriers to medication adherence. Pharmacy (Basel). 2017;5(3):52.
Torres-Robles A, Benrimoj SI, Gastelurrutia MA, et al. Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial. BMJ Qual Saf. 2022;31(2):105–15.
Michie S, Johnston M, Abraham C, et al. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care. 2005;14:26–33.
Article PubMed PubMed Central Google Scholar
Cane J, O’Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7:37.
Article PubMed PubMed Central Google Scholar
Michie S, Johnston M, Francis J, et al. From theory to intervention: mapping theoretically derived behavioural determinants to behaviour change techniques. Appl Psychol. 2008;57:660–80.
Michie S, Richardson M, Johnston M, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013;46(1):81–95.
Patton DE, Ryan C, Hughes CM. Development of a complex community pharmacy intervention package using theory-based behaviour change techniques to improve older adults’ medication adherence. BMC Health Serv Res. 2020;20(1):418.
Article PubMed PubMed Central Google Scholar
McCullough AR, Ryan C, O’Neill B, et al. Defining the content and delivery of an intervention to Change AdhereNce to treatment in BonchiEctasis (CAN-BE): a qualitative approach incorporating the theoretical domains framework, behavioural change techniques and stakeholder expert panels. BMC Health Serv Res. 2015;15:342.
Article PubMed PubMed Central Google Scholar
Crayton E, Wright AJ, Ashworth M. Improving medication adherence in stroke survivors: the intervention development process. BMC Health Serv Res. 2018;18(1):772.
Article PubMed PubMed Central Google Scholar
Félix IB, Guerreiro MP, Cavaco A, et al. Development of a complex intervention to improve adherence to antidiabetic medication in older people using an anthropomorphic virtual assistant software. Front Pharmacol. 2019;10:680.
Article PubMed PubMed Central Google Scholar
Kingir Baycar ZB, Sancar M, Ay P, et al. Short-term outcome of personalized theory-based pharmaceutical care service on the medication administration problems of family caregivers: a pre-post intervention study. Int J Clin Pharm. 2025;47(1):187–95.
Voils CI, Maciejewski ML, Hoyle RH, et al. Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Med Care. 2012;50(12):1013–9.
Article PubMed PubMed Central Google Scholar
Voils CI, King HA, Neelon B, et al. Characterizing weekly self-reported antihypertensive medication nonadherence across repeated occasions. Patient Prefer Adherence. 2014;8:643–50.
Article PubMed PubMed Central Google Scholar
Voils CI, King HA, Thorpe CT, et al. Content validity and reliability of a self-report measure of medication nonadherence in hepatitis C treatment. Dig Dis Sci. 2019;64(10):2784–97.
Voils CI, Gavin KL, Thorpe CT, et al. Validating a self-reported medication nonadherence measure in the context of multiple chronic diseases and routes of medication administration among patients with type 2 diabetes. Patient Prefer Adherence. 2022;16:3119–30.
Article PubMed PubMed Central Google Scholar
Sun K, Coles TM, Voils CI, et al. Development and initial validation of a systemic lupus erythematosus-specific measure of the extent of and reasons for medication nonadherence. J Rheumatol. 2022;49(12):1341–8.
Article PubMed PubMed Central Google Scholar
Cornelius T, Voils CI, Umland RC, et al. Validity of the self-reported domains of subjective extent of nonadherence (DOSE-nonadherence) scale in comparison with electronically monitored adherence to cardiovascular medications. Patient Prefer Adherence. 2019;13:1677–84.
Article PubMed PubMed Central Google Scholar
Lawshe CH. A quantitative approach to content validity 1. Pers Psychol. 1975;28:563–75.
Comments (0)